The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Age-related effects of optineurin deficiency in the mouse eye
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“suggesting that the OPTN(E50K) mutation results in a toxic gain of function mechanism [86].”
In the citing paper
“a more recent study demonstrated in mouse models that the OPTN(E50K) mutation decreased visual acuity, whereas visual acuity was normal in OPTN knockout mice”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wong, Y. C., & Holzbaur, E. L. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405752111 · Cited by 812
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
Ito, Y., Ofengeim, D., Najafov, A., Das, S., Saberi, S., Li, Y., Hitomi, J., Zhu, H., Chen, H., Mayo, L., et al. (2016) · Science · doi:10.1126/science.aaf6803 · Cited by 606
Zhu, G., Wu, C.-J., Zhao, Y., & Ashwell, J. D. (2007) · Current Biology · doi:10.1016/j.cub.2007.07.041 · Cited by 282
Liu, Z., Chen, P., Gao, H., Gu, Y., Yang, J., Peng, H., Xu, X., Wang, H., Yang, M., Liu, X., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.015 · Cited by 254
Chi, Z.-L., Akahori, M., Obazawa, M., Minami, M., Noda, T., Nakaya, N., Tomarev, S., Kawase, K., Yamamoto, T., Noda, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq146 · Cited by 151
Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
Toth, R. P., & Atkin, J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01017 · Cited by 114
Optineurin suppression causes neuronal cell death via NF‐κB pathway
Akizuki, M., Yamashita, H., Uemura, K., Maruyama, H., Kawakami, H., Ito, H., & Takahashi, R. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12326 · Cited by 96
Wong, S.-W., Huang, B.-W., Hu, X., Ho Kim, E., Kolb, J. P., Padilla, R. J., Xue, P., Wang, L., Oguin, T. H., Miguez, P. A., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0341-6 · Cited by 42
Self-citation
Research works printed but not linked: 56
- Ames, 2021, OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection, Nature Communications, 12, 5401, 10.1038/s41467-021-25642-z · DOI
- Anborgh, 2005, Inhibition of metabotropic glutamate receptor signaling by the huntingtin-binding protein optineurin, Journal of Biological Chemistry, 280, 34840, 10.1074/jbc.M504508200 · DOI · Paper page
- Camras, 2010, Duration of anesthesia affects intraocular pressure, but not outflow facility in mice, Current Eye Research, 35, 819, 10.3109/02713683.2010.494241 · doi:10.3109/02713683.2010.494241
- Chibalina, 2008, Rab8-optineurin-myosin VI: Analysis of interactions and functions in the secretory pathway, Methods in Enzymology, 438, 11, 10.1016/S0076-6879(07)38002-6 · DOI
- Coombs, 2006, Morphological properties of mouse retinal ganglion cells, Neuroscience, 140, 123, 10.1016/j.neuroscience.2006.02.079 · DOI · Paper page
- Del Bo, 2011, Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis, Journal of Neurology, Neurosurgery, and Psychiatry, 82, 1239, 10.1136/jnnp.2011.242313 · DOI
- del Toro, 2009, Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus, Molecular Biology of the Cell, 20, 1478, 10.1091/mbc.e08-07-0726 · DOI · Paper page
- Djamgoz, 1997, Neurobiology of retinal dopamine in relation to degenerative states of the tissue, Vision Research, 37, 3509, 10.1016/S0042-6989(97)00129-6 · DOI · Paper page
- Fecto, 2011, Making connections: Pathology and genetics link amyotrophic lateral sclerosis with frontotemporal lobe dementia, Journal of Molecular Neuroscience, 45, 663, 10.1007/s12031-011-9637-9 · DOI
- Fenner, 2009, Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays, Biochimica et Biophysica Acta, 1794, 1010, 10.1016/j.bbapap.2009.02.013 · DOI
- Gleason, 2011, Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon beta, Journal of Biological Chemistry, 286, 35663, 10.1074/jbc.M111.267567 · DOI · Paper page
- Gordon, 2002, The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma, Archives of Ophthalmology, 120, 714, 10.1001/archopht.120.6.714 · DOI · Paper page
- Gupta, 2007, Glaucoma as a neurodegenerative disease, Current Opinion in Ophthalmology, 18, 110, 10.1097/ICU.0b013e3280895aea · DOI · Paper page
- Hattula, 2000, FIP-2, a coiled-coil protein, links Huntingtin to Rab8 and modulates cellular morphogenesis, Current Biology, 10, 1603, 10.1016/S0960-9822(00)00864-2 · DOI · Paper page
- Heo, 2015, The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy, Molecular Cell, 60, 7, 10.1016/j.molcel.2015.08.016 · DOI · Paper page
- Hu, 2023, Optineurin regulates osteoblast function in an age-dependent fashion in a mouse model of Paget's disease of bone, Bone, 177, 10.1016/j.bone.2023.116929 · DOI
- Hu, 2023, Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget's disease of bone, Science Advances, 9, eade6998, 10.1126/sciadv.ade6998 · DOI
- Indrieri, 2020, Dopamine, alpha-synuclein, and mitochondrial dysfunctions in parkinsonian eyes, Frontiers in Neuroscience, 14, 10.3389/fnins.2020.567129 · DOI
- Jakobs, 2005, Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice, Journal of Cell Biology, 171, 313, 10.1083/jcb.200506099 · DOI · Paper page
- Kachaner, 2012, Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression, Molecular Cell, 45, 553, 10.1016/j.molcel.2011.12.030 · DOI
- Laplantine, 2009, NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain, The EMBO Journal, 28, 2885, 10.1038/emboj.2009.241 · DOI · Paper page
- Lin, 2013, Retinal ganglion cells are resistant to photoreceptor loss in retinal degeneration, PLoS One1, 8, e68084, 10.1371/journal.pone.0068084 · DOI
- Lin, 2004, Retinal ganglion cell type, size, and spacing can be specified independent of homotypic dendritic contacts, Neuron, 43, 475, 10.1016/j.neuron.2004.08.002 · DOI · Paper page
- Markovinovic, 2017, Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms, Progress in Neurobiology, 154, 1, 10.1016/j.pneurobio.2017.04.005 · DOI
- Maruyama, 2010, Mutations of optineurin in amyotrophic lateral sclerosis, Nature, 465, 223, 10.1038/nature08971 · DOI · Paper page
- Meng, 2012, Overexpressed mutant optineurin (E50K) induces retinal ganglion cells apoptosis via the mitochondrial pathway, Molecular Biology Reports, 39, 5867, 10.1007/s11033-011-1397-7 · DOI
- Minegishi, 2016, Significance of optineurin mutations in glaucoma and other diseases, Progress in Retinal and Eye Research, 55, 149, 10.1016/j.preteyeres.2016.08.002 · DOI
- Moreland, 2000, Identification of a transcription factor IIIA-interacting protein, Nucleic Acids Research, 28, 1986, 10.1093/nar/28.9.1986 · DOI
- Morton, 2008, Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma, FEBS Letters, 582, 997, 10.1016/j.febslet.2008.02.047 · DOI · Paper page
- Mukherjee, 2017, Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease, PLoS One1, 12, e0185242, 10.1371/journal.pone.0185242 · DOI
- Murphy, 1985, Anesthesia and intraocular pressure, Anesthesia & Analgesia, 64, 520, 10.1213/00000539-198505000-00013 · doi:10.1213/00000539-198505000-00013
- Nagabhushana, 2011, Optineurin is required for CYLD-dependent inhibition of TNFalpha-induced NF-kappaB activation, PLoS One1, 6, e17477, 10.1371/journal.pone.0017477 · DOI
- Nagabhushana, 2010, Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant, BMC Molecular and Cell Biology, 11, 4, 10.1186/1471-2121-11-4 · DOI
- Park, 2010, Impairment of protein trafficking upon overexpression and mutation of optineurin, PLoS One1, 5, e11547, 10.1371/journal.pone.0011547 · DOI
- Patil, 2022, Intrinsic antiviral activity of optineurin prevents hyperproliferation of a primary herpes simplex virus type 2 infection, Journal of Immunology, 208, 63, 10.4049/jimmunol.2100472 · DOI
- Quigley, 2006, The number of people with glaucoma worldwide in 2010 and 2020, British Journal of Ophthalmology, 90, 262, 10.1136/bjo.2005.081224 · DOI · Paper page
- Rezaie, 2002, Adult-onset primary open-angle glaucoma caused by mutations in optineurin, Science, 295, 1077, 10.1126/science.1066901 · DOI · Paper page
- Rezaie, 2005, Molecular cloning, genomic structure, and protein characterization of mouse optineurin, Genomics, 85, 131, 10.1016/j.ygeno.2004.10.011 · DOI
- Rezaie, 2005, Molecular cloning and expression profiling of optineurin in the rhesus monkey, Investigative Ophthalmology & Visual Science, 46, 2404, 10.1167/iovs.04-1243 · DOI
- Sahlender, 2005, Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis, Journal of Cell Biology, 169, 285, 10.1083/jcb.200501162 · DOI · Paper page
- Shen, 2015, Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism, Autophagy, 11, 685, 10.4161/auto.36098 · DOI · Paper page
- Shields, 2008, Normal-tension glaucoma: Is it different from primary open-angle glaucoma?, Current Opinion in Ophthalmology, 19, 85, 10.1097/ICU.0b013e3282f3919b · DOI · Paper page
- Sirohi, 2016, Defects in autophagy caused by glaucoma-associated mutations in optineurin, Experimental Eye Research, 144, 54, 10.1016/j.exer.2015.08.020 · DOI · Paper page
- Slowicka, 2016, Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-kappaB signaling, European Journal of Immunology, 46, 971, 10.1002/eji.201545863 · DOI · Paper page
- Sudhakar, 2009, NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB, PLoS One1, 4, e5114, 10.1371/journal.pone.0005114 · DOI
- Sun, 2002, Large-scale morphological survey of mouse retinal ganglion cells, The Journal of Comparative Neurology, 451, 115, 10.1002/cne.10323 · DOI · Paper page
- Tseng, 2015, Visual impairment in an optineurin mouse model of primary open angle glaucoma, Neurobiology of Aging, 36, 2201, 10.1016/j.neurobiolaging.2015.02.012 · DOI · Paper page
- Volpe, 2015, Ophthalmic manifestations of amyotrophic lateral sclerosis (An American Ophthalmological Society Thesis), Transactions of the American Ophthalmological Society, 113, T12
- Weinreb, 2014, The pathophysiology and treatment of glaucoma: A review, Journal of the American Medical Association, 311, 1901, 10.1001/jama.2014.3192 · DOI · Paper page
- Witkovsky, 2004, Dopamine and retinal function, Documenta Ophthalmologica, 108, 17, 10.1023/B:DOOP.0000019487.88486.0a · DOI · Paper page
- Wong, 2007, Age-related changes in visual acuity, learning and memory in C57BL/6J and DBA/2J mice, Neurobiology of Aging, 28, 1577, 10.1016/j.neurobiolaging.2006.07.023 · DOI
- Wong, 2015, Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria, Autophagy, 11, 422, 10.1080/15548627.2015.1009792 · DOI
- Xue, 2021, Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response, Experimental & Molecular Medicine, 53, 667, 10.1038/s12276-021-00596-w · DOI
- Yamano, 2024, Optineurin provides a mitophagy contact site for TBK1 activation, The EMBO Journal, 43, 754, 10.1038/s44318-024-00036-1 · DOI
- Ying, 2015, Induction of autophagy in rats upon overexpression of wild-type and mutant optineurin gene, BMC Molecular and Cell Biology, 16, 14, 10.1186/s12860-015-0060-x · DOI
- Zhang, 2021, The E50K optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads to RGC apoptosis in vivo and in vitro, Cell Death Discovery, 7, 49, 10.1038/s41420-021-00432-0 · DOI
Cited by
Huang, K.-C., Gomes, C., Shiga, Y., Belforte, N., VanderWall, K. B., Lavekar, S. S., Fligor, C. M., Harkin, J., Hetzer, S. M., Patil, S. V., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01872-2 · Cited by 19
Metadata
- Authors
- Su, C.-C., Liu, C., Adi, V., Chan, K. C., & Tseng, H. C.
- Venue
- Vision Research
- Publisher
- Elsevier BV
- Published
- 2024-11
- Volume
- 224
- Pages
- 108463
- ISSN
- 0042-6989
- Cited by
- 4
- References
- 8
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (am, 300 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- National Eye Institute (P30-EY005722)
- National Science and Technology Council
- Alcon Research Institute
- Research to Prevent Blindness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age-related effects of optineurin deficiency in the mouse eye. https://app.cochat.ai/papers/10.1016/j.visres.2024.108463
- The paper
- Su, C.-C., Liu, C., Adi, V., Chan, K. C., & Tseng, H. C. (2024). Age-related effects of optineurin deficiency in the mouse eye. Vision Research. https://doi.org/10.1016/j.visres.2024.108463
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.